Apyx Medical Corp
APYX · Surgical & Medical Instruments & Apparatus · 41.9M shares · +2%/yr ↑ dilution · EDGAR filings ↗
Reference price $1.13 · est. market cap ~$47M — last insider purchase, 2024-08-13 (estimated from the dated SEC Form 4 price × shares outstanding — not a live quote)
Grade
D50Medical-device maker (Renuvion/helium plasma) with operating losses, cash burn, and leverage.
Strengths
- Strong liquidity — current ratio 5.0 (73rd)
- Decent gross margin, growth — gross margin 63%, revenue +10%
Risks
- Operating/net losses — operating margin -12%, net margin -21%
- Cash burn and leverage — FCF -$9M, D/E 2.4 (88th)
- Commercialization execution — per 10-K
Notable findings
- Net lossNet loss (net margin -21.2%)
- Cash burnNegative free cash flow (-9.1M)
- Fund exitedNotable fund(s) exited this quarter: VANGUARD GROUP INC
- High leverageHigh leverage (debt/equity 2.40)
- Revenue declineRevenue -34.8% YoY
- Notable holderHeld by 4 notable fund(s): RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, CITADEL ADVISORS LLC +1 more (as of 2026-03-31)
- New fund positionNotable fund(s) opened this quarter: CITADEL ADVISORS LLC
Quarterly revenue
Last 4 quarters · from SEC filings.
Key metrics
Gross margin
62.5%
Operating margin
-12.2%
Net margin
-21.2%
Return on equity
-77.1%
Return on assets
-16.8%
ROIC
-10.3%
Revenue growth (QoQ)
-34.8%
Debt / equity
2.4×
Current ratio
5.0×
Free cash flow
-$9M
EBITDA
-$6M
Tangible book value
$15M
Cash & investments
$32M
Cash runway
14q
Stock comp / revenue
3.8%
Insider transactions · last 18 months
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-06-15 | Roman Shawn David | Option exercise | 15K | $3.23 |
| 2026-06-15 | Roman Shawn David | Tax withheld | 11K | $4.60 |
| 2026-06-11 | Vizirgianakis Stavros G. | Grant | 450K | — |
| 2026-03-15 | CITRONOWICZ MOSHE | Option exercise | 37K | $1.80 |
| 2026-01-27 | Roman Shawn David | Option exercise | 12K | $1.80 |
All non-derivative Form 4 activity (SEC), newest first.
Notable events (8-K)
Recent filings
| Form | Filed | Period | Accession |
|---|---|---|---|
| 8-K | 2026-06-17 | 2026-06-11 | 0001493152-26-029081 ↗ |
| 8-K | 2026-05-21 | 2026-05-21 | 0001437749-26-018098 ↗ |
| 8-K | 2026-05-14 | 2026-05-14 | 0001437749-26-016885 ↗ |
| 8-K | 2026-05-11 | 2026-05-11 | 0001437749-26-016000 ↗ |
| 10-Q | 2026-05-07 | 2026-03-31 | 0001437749-26-015652 ↗ |
| 8-K | 2026-05-07 | 2026-05-07 | 0001437749-26-015352 ↗ |
| 10-K | 2026-03-10 | 2025-12-31 | 0001437749-26-007471 ↗ |
| 8-K | 2026-03-10 | 2026-03-10 | 0001437749-26-007420 ↗ |
| 8-K | 2026-01-12 | 2026-01-12 | 0001437749-26-001048 ↗ |
| 8-K | 2025-12-12 | 2025-12-08 | 0001493152-25-027481 ↗ |
| 8-K | 2025-11-19 | 2025-11-17 | 0001493152-25-024279 ↗ |
| 8-K | 2025-11-06 | 2025-11-06 | 0001437749-25-033456 ↗ |